Lymphoid infiltrates; abundant plasma cells; EBV-encoded RNA (EBER)-positive tumor cells; latency I-II pattern; immunohistochemistry (IHC); in situ hybridization (ISH); CD3-positive T-cells; CD20-positive B-cells; carcinoma cells clustered in groups; nuclear atypia